Cardiovascular disease/Cardiac rehabilitation
Conditions
Interventions
Study Group:CPET
Study Group:6MWT
Study Group:Physical Fitness Assessment Form
Study Group:MLWHFQ
Study Group:ADL
Study Group:PHQ-9
Study Group:GAD-7
Study Group:FTND
Study Group:ECG monitoring of dynamic ECG recorder
Control Group:CPET
Control Group:6MWT
Control Group:Physical Fitness Assessment Form
Control Group:MLWHFQ
Control Group:ADL
Control Group:PHQ-9
Control Group:GAD-7
Control Group:FTND
Sponsors
Zhejiang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Aged >= 18 years, regardless of gender; (2) Because of cardiovascular disease (such as CHD, After PCI, hypertension, PAO, cardiac arrhythmia, CHF, etc.) after hospitalization, discharged patients, and outpatients; (3) The risk level is low or medium; (4) Sign informed consent; (5) Relevant patients considered suitable for inclusion by the researchers.
Exclusion criteria
Exclusion criteria: (1) Unstable angina pectoris; (2) Patients with systolic pressure > 200mmHg or diastolic pressure > 110mmHg at rest or patients with blood pressure drop > 20mmHg and symptoms after standing up; (3) Severe aortic stenosis; (4) Acute systemic disease or fever; (5) Uncontrolled severe atrial or ventricular arrhythmia, uncontrolled significant sinus tachycardia (>120 beats/min) ; (6) Uncontrolled heart failure, third degree atrioventricular block with no pacemaker; (7) Active pericarditis or myocarditis, thrombophlebitis, recent thromboembolism, ST segment depression or elevation at rest (>2 mm); (8) Severe motor system abnormalities that can limit exercise ability and other metabolic abnormalities, such as acute thyroiditis, hypokalemia, hyperkalemia or hypovolemia; (9) Gestation period; (10) Patients with severe mental illness or dementia who cannot cooperate; (11) Patients considered unsuitable by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VO2peak, ml/min;VO2max,ml /min/kg;AT, ml/min;METs;FVC;FEV1;FEV1/FVC;6MWTPositioning walking distance;Incidence of cardiovascular adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical Fitness Assessment Form;MLWHFQ;ADL;PHQ-9;GAD-7;FTND; | — |
Countries
China
Contacts
Public ContactYan Jing
Zhejiang Hospital
Outcome results
None listed